title: Molecular determinants of cardiac Ca2+ channel pharmacology. Subunit requirement for the high affinity and allosteric regulation of dihydropyridine binding.
abstract: Cardiac L-type Ca2+ channels are multisubunit complexes composed of alpha 1C, alpha 2 delta, and beta 2 subunits. We tested the roles of these subunits in forming a functional complex by characterizing the effects of subunit composition on dihydropyridine binding, its allosteric regulation, and the ability of dihydropyridines to inhibit channel activity. Transfection of COS.M6 cells with cardiac alpha 1C-a (alpha 1) led to the appearance of dihydropyridine ([3H]PN200-110) binding which was increased by coexpression of cardiac beta 2a (beta), alpha 2 delta a (alpha 2), and the skeletal muscle gamma. Maximum binding was achieved when cells expressed alpha 1, beta, and alpha 2. Cells transfected with alpha 1 and beta had a binding affinity that was 5-10-fold lower than that observed in cardiac membranes. Coexpression of alpha 2 normalized this affinity. (-)-D600 and diltiazem both partially inhibited PN200-100 binding to cardiac microsomes, but stimulated binding in cells transfected with alpha 1 and beta. Again, coexpression of alpha 2 normalized this allosteric regulation. Therefore coexpression of alpha 1 beta and alpha 2 completely reconstituted high affinity dihydropyridine binding and its allosteric regulation as observed in cardiac membranes. Skeletal muscle gamma was not required for this reconstitution. Expression in Xenopus oocytes demonstrated that coexpression of alpha 2 with alpha 1 beta increased the potency and maximum extent of block of Ca2+ channel currents by nisoldipine, a dihydropyridine Ca2+ channel antagonist. Our results demonstrate that alpha 2 subunits are essential components of the cardiac L-type Ca2+ channel and predict a minimum subunit composition of alpha 1C beta 2 alpha 2 delta for this channel.
authors.affiliation: Institute for Molecular Medicine and Genetics, Medical College of Georgia, Augusta 30912, USA.
authors.forename: X
authors.initials: X
authors.lastname: Wei
authors.forename: S
authors.initials: S
authors.lastname: Pan
authors.forename: W
authors.initials: W
authors.lastname: Lang
authors.forename: H
authors.initials: H
authors.lastname: Kim
authors.forename: T
authors.initials: T
authors.lastname: Schneider
authors.forename: E
authors.initials: E
authors.lastname: Perez-Reyes
authors.forename: L
authors.initials: L
authors.lastname: Birnbaumer
mesh_terms: D000494:Allosteric Regulation; D000818:Animals; D015220:Calcium Channels / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D018076:DNA, Complementary / Q000235:genetics; D004095:Dihydropyridines / Q000378:metabolism*; D004110:Diltiazem / Q000494:pharmacology; D005260:Female; D007700:Kinetics; D008024:Ligands; D015394:Molecular Structure; D018482:Muscle, Skeletal / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D015737:Nisoldipine / Q000494:pharmacology; D009865:Oocytes / Q000378:metabolism; D011487:Protein Conformation; D011817:Rabbits; D014162:Transfection; D014981:Xenopus
chemical_list: D015220:Calcium Channels; D018076:DNA, Complementary; D004095:Dihydropyridines; D008024:Ligands; D015737:Nisoldipine; C038806:1,4-dihydropyridine; D004110:Diltiazem